UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 11, 2018
Accession Number:
0001193125-18-109012
Submission Type:
POS AM
CIK:
0000882361
Company Name:
Aptose Biosciences Inc.
File Number:
333-221783